Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease

Study Title
A Randomized Placebo Controlled Study to Show That Rasagiline May Slow Disease Progression for Parkinson's Disease
Teva Identifier
TVP-1012/500 (ADAGIO)
ClinicalTrials.gov Identifier
NCT00256204
Study Status
Completed
Trial Condition(s)
Parkinson's Disease
Interventions
Drug: Rasagiline Mesylate | Other: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
30 Years to 80 Years
Trial Duration
11/01/2005 - 06/01/2009
Phase
Phase 3

Study Type

Interventional